KONCERT A Kaletra ONCE Daily Randomised Trial of the Pharmacokinetics, Safety and Efficacy of Twice-daily Versus Once-daily Lopinavir/Ritonavir Tablets Dosed by Weight as Part of Combination Antiretroviral Therapy in Human Immunodeficiency Virus-1 (HIV-1) Infected Children (PENTA 18)
Clinical trial NCT01196195 · COMPLETED
Trial details
- NCT number
- NCT01196195
- Sponsor
- PENTA Foundation
- Status
- COMPLETED
- Phase
- Phase 2, Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2010-08-01
- Primary completion
- 2012-07-01
- Enrollment
- 173
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.